371 related articles for article (PubMed ID: 33839994)
1. Overview of the Neuroprotective Effects of the MAO-Inhibiting Antidepressant Phenelzine.
Matveychuk D; MacKenzie EM; Kumpula D; Song MS; Holt A; Kar S; Todd KG; Wood PL; Baker GB
Cell Mol Neurobiol; 2022 Jan; 42(1):225-242. PubMed ID: 33839994
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of the effects of oxidative stress by the MAO-inhibiting antidepressant and carbonyl scavenger phenelzine.
Baker G; Matveychuk D; MacKenzie EM; Holt A; Wang Y; Kar S
Chem Biol Interact; 2019 May; 304():139-147. PubMed ID: 30857888
[TBL] [Abstract][Full Text] [Related]
3. Neurochemical effects of the monoamine oxidase inhibitor phenelzine on brain GABA and alanine: A comparison with vigabatrin.
Todd KG; Baker GB
J Pharm Pharm Sci; 2008 May; 11(2):14s-21s. PubMed ID: 19203467
[TBL] [Abstract][Full Text] [Related]
4. GABA-elevating effects of the antidepressant/antipanic drug phenelzine in brain: effects of pretreatment with tranylcypromine, (-)-deprenyl and clorgyline.
Todd KG; Baker GB
J Affect Disord; 1995 Dec; 35(3):125-9. PubMed ID: 8749840
[TBL] [Abstract][Full Text] [Related]
5. Time-dependent changes in brain monoamine oxidase activity and in brain levels of monoamines and amino acids following acute administration of the antidepressant/antipanic drug phenelzine.
Parent MB; Habib MK; Baker GB
Biochem Pharmacol; 2000 May; 59(10):1253-63. PubMed ID: 10736426
[TBL] [Abstract][Full Text] [Related]
6. Phenelzine causes an increase in brain ornithine that is prevented by prior monoamine oxidase inhibition.
MacKenzie EM; Grant SL; Baker GB; Wood PL
Neurochem Res; 2008 Mar; 33(3):430-6. PubMed ID: 17768678
[TBL] [Abstract][Full Text] [Related]
7. Effects of the antidepressant/antipanic drug phenelzine and its putative metabolite phenylethylidenehydrazine on extracellular gamma-aminobutyric acid levels in the striatum.
Parent MB; Master S; Kashlub S; Baker GB
Biochem Pharmacol; 2002 Jan; 63(1):57-64. PubMed ID: 11754874
[TBL] [Abstract][Full Text] [Related]
8. The antidepressant phenelzine protects neurons and astrocytes against formaldehyde-induced toxicity.
Song MS; Baker GB; Dursun SM; Todd KG
J Neurochem; 2010 Sep; 114(5):1405-13. PubMed ID: 20557421
[TBL] [Abstract][Full Text] [Related]
9. Effects of the MAO inhibitor phenelzine on glutamine and GABA concentrations in rat brain.
Paslawski TM; Sloley BD; Baker GB
Prog Brain Res; 1995; 106():181-6. PubMed ID: 8584653
[TBL] [Abstract][Full Text] [Related]
10. Chronic administration of the antidepressant phenelzine and its N-acetyl analogue: effects on GABAergic function.
McKenna KF; McManus DJ; Baker GB; Coutts RT
J Neural Transm Suppl; 1994; 41():115-22. PubMed ID: 7931216
[TBL] [Abstract][Full Text] [Related]
11. Elevation of rat brain tyrosine levels by phenelzine is mediated by its active metabolite β-phenylethylidenehydrazine.
Matveychuk D; Nunes E; Ullah N; Aldawsari FS; Velázquez-Martínez CA; Baker GB
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():67-73. PubMed ID: 24607770
[TBL] [Abstract][Full Text] [Related]
12. The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA.
Paslawski T; Treit D; Baker GB; George M; Coutts RT
Psychopharmacology (Berl); 1996 Sep; 127(1):19-24. PubMed ID: 8880939
[TBL] [Abstract][Full Text] [Related]
13. Comparison of phenelzine and geometric isomers of its active metabolite, β-phenylethylidenehydrazine, on rat brain levels of amino acids, biogenic amine neurotransmitters and methylamine.
Matveychuk D; Nunes E; Ullah N; Velázquez-Martinez CA; MacKenzie EM; Baker GB
J Neural Transm (Vienna); 2013 Jun; 120(6):987-96. PubMed ID: 23392617
[TBL] [Abstract][Full Text] [Related]
14. Chronic administration of the antidepressant-antipanic drug phenelzine and its N-acetylated analogue: effects on monoamine oxidase, biogenic amines, and alpha 2-adrenoreceptor function.
McKenna KF; Baker GB; Coutts RT; Greenshaw AJ
J Pharm Sci; 1992 Aug; 81(8):832-5. PubMed ID: 1383493
[TBL] [Abstract][Full Text] [Related]
15. Task-dependent effects of the antidepressant/antipanic drug phenelzine on memory.
Parent MB; Habib MK; Baker GB
Psychopharmacology (Berl); 1999 Mar; 142(3):280-8. PubMed ID: 10208320
[TBL] [Abstract][Full Text] [Related]
16. The antidepressant phenelzine enhances memory in the double Y-maze and increases GABA levels in the hippocampus and frontal cortex of rats.
Simpson SM; Hickey AJ; Baker GB; Reynolds JN; Beninger RJ
Pharmacol Biochem Behav; 2012 Jul; 102(1):109-17. PubMed ID: 22503968
[TBL] [Abstract][Full Text] [Related]
17. Comparison of neurochemical effects of the monoamine oxidase inhibitors phenelzine, moclobemide and brofaromine in the rat after short- and long-term administration.
Urichuk LJ; Allison K; Holt A; Greenshaw AJ; Baker GB
J Affect Disord; 2000 May; 58(2):135-44. PubMed ID: 10781703
[TBL] [Abstract][Full Text] [Related]
18. The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE).
Benson CA; Wong G; Tenorio G; Baker GB; Kerr BJ
Behav Brain Res; 2013 Sep; 252():302-11. PubMed ID: 23777648
[TBL] [Abstract][Full Text] [Related]
19. Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine-oxidase activity and monoamine levels.
Griebel G; Curet O; Perrault G; Sanger DJ
Neuropharmacology; 1998 Jul; 37(7):927-35. PubMed ID: 9776388
[TBL] [Abstract][Full Text] [Related]
20. Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders?
Baker GB; Sowa B; Todd KG
J Psychiatry Neurosci; 2007 Sep; 32(5):313-5. PubMed ID: 17823646
[No Abstract] [Full Text] [Related]
[Next] [New Search]